PMD Psychemedics Corp.

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company's revenue generation and growth strategies.

With an exceptional track record of leadership and a strong background in revenue growth and optimization, Shoemaker brings a wealth of experience to her new position. Her appointment marks a significant milestone for Psychemedics Corporation as it continues to expand its presence in the rapidly evolving field of substance abuse testing.

"We are thrilled to welcome Shannon Shoemaker to Psychemedics as our new Chief Revenue Officer," said Brian Hullinger, CEO of Psychemedics Corporation. "Shannon's impressive track record and dedication to excellence make her the ideal candidate to lead our strategic growth initiatives. We look forward to her contributions as we continue to innovate and grow in the industry."

Shannon Shoemaker brings a wealth of experience to her role as the new Chief Revenue Officer at Psychemedics Corporation. Her career is marked by exceptional strategic leadership, consistently delivering outstanding results. Shoemaker's ability to lead high-performing teams and develop successful growth strategies has led to the expansion of market presence, both domestically and internationally. Shoemaker's career has been characterized by outstanding accomplishments and a dedication to excellence. She has received numerous accolades and awards throughout her professional career, including Business Women of the Year by CEO Today, The 10 Most Influential Businesswomen by CIO Look, and The 20 Most Successful Businesswomen to Watch by Insights Success.

For more information about Psychemedics Corporation and its innovative hair testing solutions, please visit.

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:

Phone: 978-206-8220

Email:  

 



EN
21/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Psychemedics Corp.

 PRESS RELEASE

Psychemedics Releases 2025 Workforce Insights Report

Psychemedics Releases 2025 Workforce Insights Report Synthetic Drug Threats and Legalization Risks Shape a New Era for Workplace Safety DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a comprehensive look at the evolving drug landscape and its impact on workplace safety, hiring practices, and employer risk. The 2025 Psychemedics Insights Report draws from the largest proprietary database of hair drug testing results in the industr...

 PRESS RELEASE

Psychemedics Named “Most Innovative Drug Testing Company of the Year”

Psychemedics Named “Most Innovative Drug Testing Company of the Year” DALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of its prestigious 2025 Global Excellence Awards. This recognition honors Psychemedics’ continued leadership in advancing the science of drug detection, including the recent launch of its Enhanced Quartile Reporting. This breakthrough analytics tool provides deeper insi...

 PRESS RELEASE

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced D...

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces. The new Quartile Reporting feature allows clients to see where a candidate’s or employee’s test results fall within a range o...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 14, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch